Offering the highest quality of filtration available, the MADA 83 Series spirometry filters are simple and effective to use. The unique 3D mouthpiece design curves with the face and mouth to create a superior seal and a nose-clip is supplied to optimise this seal even further.
With a bacterial filtration efficiency of 99.99% as well as a viral filtration efficiency of 99.99%, the MADA 83 Series is in a league of its own in the spirometry market.
MADA Spirometry Filters 83 Series are available economical boxes of 100 pieces.
Please choose the correct filter for the machine being used.
Item Number 175-30886 (Orange): Use with Viasys & Jaeger Machines Item Number 175-30887 (Yellow): Use with MicroMedical, Mir & Vitalograph Machines Item Number 175-30888 (Blue): Use with Medical Graphics Machines Item Number 175-30889 (Green): Use with Cosmed & Medisoft Machines
For more information please call Getz Healthcare or use the MedicalSearch email enquiry for a direct reply.
Getz Healthcare Australia | Medical Devices & Services
Getz Healthcare Pty Limited is a supplier of high-end technology products and services to the medical and allied health care industry, with sales and service offices located across Australia and New Zealand since 1965.
Partnering with prominent global industry leaders, Getz Healthcare offers the latest in medical technology and is driven by the mission to make lives better through quality products and exceptional service.
Our extensive range of innovative, high quality products and integrated solutions work together to create an efficient and effective working environment for our customers, allowing them to focus on greater patient care.
In July 2018, Getz Healthcare acquired Medical Technologies Pty Ltd as a critical building block in Getz Healthcare’s strategy to expand the distribution and service business in Australia and New Zealand.
Headquartered in Singapore, Getz Healthcare has operations in nine countries across the region, partnering with leading manufacturers and innovators of medical technology to become "Medtech companies pathway to Asia Pacific"?.